Angioplasty catheter manufacturer AngioScore successfully initiated a 1st-in-human trial evaluating its CardioSculpt valvuloplasty scoring balloon in treatment of critical aortic valve stenosis.
The study will enroll 30 patients with symptomatic critical aortic valve stenosis who are not eligible for transcatheter treatment or surgical valve replacement.